Veru announces reverse stock split

Miami, fl, aug. 06, 2025 (globe newswire) -- veru inc. (nasdaq: veru), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that it will effect a 1-for-10 reverse stock split of its shares of common stock. the reverse stock split will become effective at 11:59 pm ct on friday, august 8, 2025. the company's common stock is expected to begin trading on the nasdaq capital market under the same symbol (veru) on a split-adjusted basis at the market open on august 11, 2025 with the new cusip number 92536c202.
VERU Ratings Summary
VERU Quant Ranking